219 related articles for article (PubMed ID: 31771769)
21. Renal cell carcinoma: Children's Hospital Boston experience.
Estrada CR; Suthar AM; Eaton SH; Cilento BG
Urology; 2005 Dec; 66(6):1296-300. PubMed ID: 16360460
[TBL] [Abstract][Full Text] [Related]
22. [Urologic malignancies in renal transplant candidates and recipients].
Kleinclauss F; Thuret R; Murez T; Timsit MO
Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
[TBL] [Abstract][Full Text] [Related]
23. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
24. Renal cell carcinoma: current status and emerging therapies.
Nelson EC; Evans CP; Lara PN
Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
[TBL] [Abstract][Full Text] [Related]
25. Pediatric and adolescent renal cell carcinoma.
Young EE; Brown CT; Merguerian PA; Akhavan A
Urol Oncol; 2016 Jan; 34(1):42-9. PubMed ID: 26299882
[TBL] [Abstract][Full Text] [Related]
26. Contemporary Systemic Therapy for Urologic Malignancies in Geriatric Patients.
Zhao B; Grivas PD
Clin Geriatr Med; 2015 Nov; 31(4):645-65. PubMed ID: 26476122
[TBL] [Abstract][Full Text] [Related]
27. [Active surveillance for renal cell carcinoma].
Doehn C; Witzsch U; Siebels M
Aktuelle Urol; 2012 Jul; 43(4):243-9. PubMed ID: 22869494
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
Smaldone MC; Fung C; Uzzo RG; Haas NB
Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
[TBL] [Abstract][Full Text] [Related]
29. The role of active surveillance of small renal masses.
Volpe A
Int J Surg; 2016 Dec; 36(Pt C):518-524. PubMed ID: 27321381
[TBL] [Abstract][Full Text] [Related]
30. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Management of Hereditary Renal Cell Cancer.
Menko FH; Maher ER
Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
[TBL] [Abstract][Full Text] [Related]
32. Treatment of elderly patients with metastatic renal cell carcinoma.
Zanardi E; Grassi P; Cavo A; Verzoni E; Maggi C; De Braud F; Boccardo F; Procopio G
Expert Rev Anticancer Ther; 2016; 16(3):323-34. PubMed ID: 26654225
[TBL] [Abstract][Full Text] [Related]
33. Incidental renal tumours.
Patard JJ
Curr Opin Urol; 2009 Sep; 19(5):454-8. PubMed ID: 19571758
[TBL] [Abstract][Full Text] [Related]
34. EAU guidelines on renal cell carcinoma: the 2010 update.
Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
[TBL] [Abstract][Full Text] [Related]
35. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
[TBL] [Abstract][Full Text] [Related]
36. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
Soares A; Monteiro FSM; Maluf FC; Bastos DA; Jardim DL; Sasse AD; Gonçalves E Silva A; Fay AP; da Rosa DAR; Wierman E; Kater F; Schutz FA; de Oliveira FNG; Morbeck IAP; Rinck JA; da Trindade KM; Maia MC; Souza VC; da Silva Neto DCV; de Almeida E Paula F; Korkes F; Carvalhal GF; Nogueira L; de Carvalho Fernandes R; Dos Reis RB; Matheus WE; Busato WFS; da Costa WH; de Cássio Zequi S
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1829-1845. PubMed ID: 32410064
[TBL] [Abstract][Full Text] [Related]
37. The genomics of renal cell carcinoma and its role in renal mass biopsy.
Salami SS; George AK; Udager AM
Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
[TBL] [Abstract][Full Text] [Related]
38. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
[TBL] [Abstract][Full Text] [Related]
39. Surgical management of large renal tumors.
Wszolek MF; Wotkowicz C; Libertino JA
Nat Clin Pract Urol; 2008 Jan; 5(1):35-46. PubMed ID: 18185512
[TBL] [Abstract][Full Text] [Related]
40. [Incidental renal cell carcinoma: analysis of 109 cases].
Yang G; Chen Z; Peng Y; Liu W; Tao L
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):445-7. PubMed ID: 12139804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
